Get notified when RGNX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern, and the auditor's report includes a going concern explanatory paragraph.
REGENXBIO files preliminary prospectus for common stock offering; terms not yet set
Filed July 16, 2026 · ~1 min read
Key Changes
-
high
Offering terms (number of shares and price) are left blank in this preliminary prospectus supplement; underwriters have a 30-day option for additional shares.
The Offering verify on EDGAR → -
medium
Net proceeds are estimated but blank; company plans to use them for general corporate purposes with broad management discretion.
Use of Proceeds verify on EDGAR → -
medium
As of March 31, 2026, 51,617,233 shares outstanding; options, RSUs, PSUs, and warrants could add over 16 million shares.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SPWH 10-Q) is open in full — no account needed.
Partner
Trade RGNX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify